Astera Labs (NASDAQ:ALAB) Shares Gap Down – Should You Sell?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price gapped down prior to trading on Tuesday. The stock had previously closed at $324.11, but opened at $309.32. Astera Labs shares last traded at $314.3980, with a volume of 855,276 shares.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Barclays raised their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Bank of America upped their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Citigroup cut Astera Labs from a “buy” rating to a “hold” rating in a report on Friday. Stifel Nicolaus raised their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Finally, Susquehanna raised their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Eleven investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Price Performance

The business’s 50 day moving average price is $317.50 and its 200-day moving average price is $292.99. The company has a market cap of $55.36 billion, a P/E ratio of 157.22 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 2.70 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the completion of the transaction, the director directly owned 2,648 shares of the company’s stock, valued at $995,806.88. This represents a 77.25% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 408,558 shares of company stock valued at $127,306,034 over the last quarter. 10.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently added to or reduced their stakes in the business. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs during the second quarter valued at $25,000. Archer Investment Corp bought a new position in shares of Astera Labs in the 2nd quarter worth about $30,000. Transamerica Financial Advisors LLC bought a new position in shares of Astera Labs in the 2nd quarter worth about $35,000. Continuum Advisory LLC bought a new position in shares of Astera Labs in the 2nd quarter worth about $37,000. Finally, GK Wealth Management LLC acquired a new position in shares of Astera Labs in the 3rd quarter valued at about $29,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.